ClinicalTrials HQ

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Recruiting · NCT06784752 · Registry updated 2026-09-11
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NETHemic and Lymphatic Diseases, Neoplasms by Histologic Type, digestive system neuroendocrine neoplasm, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 32026-09-11NCT06784752

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AdventHealthOrlandoUnited States29
Blue Ridge Cancer CenterWythevilleUnited States2
Hartford HospitalHartfordUnited States131
Henry Ford HospitalDetroitUnited States6
Highlands Oncology GroupFayettevilleUnited States16
LSU Medical CenterNew OrleansUnited States1
Mayo Clinic ArizonaScottsdaleUnited States34
Mayo Clinic JacksonvilleJacksonvilleUnited States67
Mount Sinai Medical CenterNew YorkUnited States1
Northwest Medical SpecialtiesTacomaUnited States32
Piedmont HealthcareAtlantaUnited States13
Rocky Mountain Cancer CentersDenverUnited States26
St Elizabeth HealthcareEdgewoodUnited States3
Tennessee OncologyNashvilleUnited States77
Texas OncologyDallasUnited States7
TxO Austin MidtownAustinUnited States2
Virginia Cancer SpecialistsFairfaxUnited States109
Virginia Oncology AssociatesNorfolkUnited States73
Winship Cancer InstituteAtlantaUnited States28
Yale New Haven HospitalNew HavenUnited States27